Department of Emergency Medicine, Landspitali – The National University Hospital of Iceland, Reykjavik, Iceland
Search for other papers by Lára Ósk Eggertsdóttir Claessen in
Google Scholar
PubMed
Search for other papers by Hafrún Kristjánsdóttir in
Google Scholar
PubMed
Department of Psychology, School of Social Sciences, Reykjavik University, Reykjavik, Iceland
Search for other papers by María Kristín Jónsdóttir in
Google Scholar
PubMed
School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland
Search for other papers by Sigrún Helga Lund in
Google Scholar
PubMed
Search for other papers by Ingunn Unnsteinsdóttir Kristensen in
Google Scholar
PubMed
Department of Medicine, Landspitali – The National University Hospital of Iceland, Reykjavik, Iceland
Search for other papers by Helga Ágústa Sigurjónsdóttir in
Google Scholar
PubMed
expensive, a biochemical marker for GHD screening would be beneficial. Serum insulin-like growth factor 1 (s-IGF1) has been proposed as a screening tool for GHD as low s-IGF1 may indicate GHD. However, its use remains debatable as s-IGF1 within normal range
Search for other papers by Danielle Christine Maria van der Kaay in
Google Scholar
PubMed
Search for other papers by Anne Rochtus in
Google Scholar
PubMed
Search for other papers by Gerhard Binder in
Google Scholar
PubMed
Search for other papers by Ingo Kurth in
Google Scholar
PubMed
Search for other papers by Dirk Prawitt in
Google Scholar
PubMed
Search for other papers by Irène Netchine in
Google Scholar
PubMed
Department of Endocrinology at Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Gudmundur Johannsson in
Google Scholar
PubMed
Search for other papers by Anita C S Hokken-Koelega in
Google Scholar
PubMed
Search for other papers by Miriam Elbracht in
Google Scholar
PubMed
Search for other papers by Thomas Eggermann in
Google Scholar
PubMed
radiologic and clinical examinations suggest an endocrine cause of the growth disturbance, growth hormone stimulation tests (GHSTs), serum insulin-like growth factor (IGF1), and sometimes an IGF1 generation test are used to investigate the growth hormone (GH)–IGF
Search for other papers by Alberto Battezzati in
Google Scholar
PubMed
Search for other papers by Andrea Foppiani in
Google Scholar
PubMed
Search for other papers by Gianfranco Alicandro in
Google Scholar
PubMed
Search for other papers by Arianna Bisogno in
Google Scholar
PubMed
Search for other papers by Arianna Biffi in
Google Scholar
PubMed
Internal Medicine, S. Maria delle Croci Hospital, AUSL Romagna, Ravenna, Italy
Search for other papers by Giorgio Bedogni in
Google Scholar
PubMed
Istituto Auxologico Italiano, IRCCS, Obesity Unit - Laboratory of Nutrition and Obesity Research, Department of Endocrine and Metabolic Diseases, Milan, Italy
Search for other papers by Simona Bertoli in
Google Scholar
PubMed
Search for other papers by Giulia De Carlo in
Google Scholar
PubMed
Search for other papers by Erica Nazzari in
Google Scholar
PubMed
Search for other papers by Carla Colombo in
Google Scholar
PubMed
studies in type 1 diabetes and in healthy subjects. According to mechanistic studies, insulin is one of the main regulators of growth hormone (GH)/insulin-like growth factor 1 (IGF-1) axis ( 21 ), frequently involved in growth failure associated with
Search for other papers by Mei Li in
Google Scholar
PubMed
Search for other papers by Yanfei Chen in
Google Scholar
PubMed
Search for other papers by Binrong Liao in
Google Scholar
PubMed
Search for other papers by Jing Tang in
Google Scholar
PubMed
Search for other papers by Jingzi Zhong in
Google Scholar
PubMed
Search for other papers by Dan Lan in
Google Scholar
PubMed
-2000i, Shenzhen, China), with intra- and inter-assay CVs of LH, FSH, and E2 less than 10%. Insulin-like growth factor-1 (IGF-1) was tested by chemiluminescence (BIOBASE, MAGLUMI 4000 plus, Shandong, China). The serum MKRN3 and kisspeptin levels were
Search for other papers by Yu Ah Hong in
Google Scholar
PubMed
Search for other papers by Kyung-Do Han in
Google Scholar
PubMed
Search for other papers by Jae-Seung Yun in
Google Scholar
PubMed
Search for other papers by Eun Sil Sil in
Google Scholar
PubMed
Search for other papers by Seung-Hyun Ko in
Google Scholar
PubMed
Search for other papers by Sungjin Chung in
Google Scholar
PubMed
growth hormone/insulin-like growth factor-1 (GH/IGF-1) system. IGF-1 levels were reported to be positively associated with height ( 30 , 31 ). The kidney is a significant source of IGF-1 synthesis, some of which is released into circulation. In addition
Search for other papers by Ekaterina Koledova in
Google Scholar
PubMed
Search for other papers by George Stoyanov in
Google Scholar
PubMed
Search for other papers by Leroy Ovbude in
Google Scholar
PubMed
Search for other papers by Peter S W Davies in
Google Scholar
PubMed
(marital and employment status). Secondary endpoints included changes from baseline in growth outcomes and insulin-like growth factor 1 (IGF1) concentrations. Suspected serious adverse events (SAEs) that occurred during the study were collected and
Search for other papers by Adrian F Daly in
Google Scholar
PubMed
Search for other papers by David A Cano in
Google Scholar
PubMed
Search for other papers by Eva Venegas-Moreno in
Google Scholar
PubMed
Search for other papers by Patrick Petrossians in
Google Scholar
PubMed
Search for other papers by Elena Dios in
Google Scholar
PubMed
Search for other papers by Emilie Castermans in
Google Scholar
PubMed
Search for other papers by Alvaro Flores-Martínez in
Google Scholar
PubMed
Search for other papers by Vincent Bours in
Google Scholar
PubMed
Search for other papers by Albert Beckers in
Google Scholar
PubMed
Search for other papers by Alfonso Soto-Moreno in
Google Scholar
PubMed
worse response to treatment with SST2-specific SSA compared with AIP wild-type acromegaly controls, both in terms of smaller IGF-1 decreases and less tumor shrinkage. In acromegaly patients without AIP mut, it has also been suggested that AIP
Search for other papers by Silvia Ciancia in
Google Scholar
PubMed
Search for other papers by Vanessa Dubois in
Google Scholar
PubMed
Search for other papers by Martine Cools in
Google Scholar
PubMed
childhood, followed by a sharp acceleration from the onset of puberty onward, up to early adulthood. During puberty, the growth hormone (GH)/insulin-like growth factor (IGF)-1 axis and sex steroids become the main determinants of bone development, acting on
Developmental Endocrinology Research Group, University of Glasgow, Glasgow, UK
Search for other papers by M Guftar Shaikh in
Google Scholar
PubMed
Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK
Search for other papers by Timothy G Barrett in
Google Scholar
PubMed
Search for other papers by Nicola Bridges in
Google Scholar
PubMed
Search for other papers by Robin Chung in
Google Scholar
PubMed
Centre for Endocrinology, William Harvey Research Institute, Barts and The London Medical School, Queen Mary University of London, London, UK
Search for other papers by Evelien F Gevers in
Google Scholar
PubMed
Department of Endocrinology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK
Search for other papers by Anthony P Goldstone in
Google Scholar
PubMed
Search for other papers by Anthony Holland in
Google Scholar
PubMed
Search for other papers by Shankar Kanumakala in
Google Scholar
PubMed
Search for other papers by Ruth Krone in
Google Scholar
PubMed
Department of Paediatric Endocrinology, Makarios Children's Hospital, Nicosia, Cyprus
Search for other papers by Andreas Kyriakou in
Google Scholar
PubMed
Sussex Community NHS Trust, Brighton, UK
Search for other papers by E Anne Livesey in
Google Scholar
PubMed
Developmental Endocrinology Research Group, University of Glasgow, Glasgow, UK
Search for other papers by Angela K Lucas-Herald in
Google Scholar
PubMed
Search for other papers by Christina Meade in
Google Scholar
PubMed
Search for other papers by Susan Passmore in
Google Scholar
PubMed
The University of Dublin, Trinity College Dublin, Dublin, Republic of Ireland
Search for other papers by Edna Roche in
Google Scholar
PubMed
Search for other papers by Chris Smith in
Google Scholar
PubMed
Search for other papers by Sarita Soni in
Google Scholar
PubMed
). GH-treated patients had higher scores in visuospatial and abstract reasoning ( 65 , 69 ). The mechanism for this is unclear, though it is suggested that GH and/or IGF-1 has a direct effect on the brain. However, a recent meta-analysis demonstrated GH
Search for other papers by Marilena Nakaguma in
Google Scholar
PubMed
Search for other papers by Fernanda A Correa in
Google Scholar
PubMed
Search for other papers by Lucas S Santana in
Google Scholar
PubMed
Search for other papers by Anna F F Benedetti in
Google Scholar
PubMed
Search for other papers by Ricardo V Perez in
Google Scholar
PubMed
Search for other papers by Martha K P Huayllas in
Google Scholar
PubMed
Search for other papers by Mirta B Miras in
Google Scholar
PubMed
Search for other papers by Mariana F A Funari in
Google Scholar
PubMed
Search for other papers by Antonio M Lerario in
Google Scholar
PubMed
Search for other papers by Berenice B Mendonca in
Google Scholar
PubMed
Search for other papers by Luciani R S Carvalho in
Google Scholar
PubMed
Search for other papers by Alexander A L Jorge in
Google Scholar
PubMed
Search for other papers by Ivo J P Arnhold in
Google Scholar
PubMed
-visualized posterior pituitary; TPP, topic posterior pituitary lobe. Serum levels of TSH, GH, LH, FSH, PRL, cortisol, dehydroepiandrosterone sulphate, total thyroxine, free thyroxine, insulin-like growth factor 1 (IGF-1), oestradiol or testosterone levels